Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial.

Mauge L, Mejean A, Fournier L, Pereira H, Etienne-Grimaldi MC, Levionnois E, Caty A, Abadie-Lacourtoisie S, Culine S, Le Moulec S, Linassier C, Théodore C, Ravaud A, Albiges L, Grine A, Tartour E, Milano G, Gille AS, Verkarre V, Helley D, Oudard S; PREINSUT study group.

Clin Cancer Res. 2018 Jul 30. doi: 10.1158/1078-0432.CCR-18-1045. [Epub ahead of print]

PMID:
30061359
2.

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study.

Colomba E, Le Teuff G, Eisen T, Stewart GD, Fife K, Larkin J, Biondo A, Pickering L, Srinivasan A, Boyle H, Derosa L, Sternberg CN, Recine F, Ralph C, Saldana C, Barthélémy P, Bernhard JC, Gurney H, Verhoest G, Vauleon E, Bigot P, Berger J, Pfister C, Gravis G, Rodier JM, Culine S, Caty A, Rolland F, Priou F, Escudier B, Albiges L.

Eur J Cancer. 2017 Jul;80:55-62. doi: 10.1016/j.ejca.2017.03.011. Epub 2017 May 23.

PMID:
28549248
3.

Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.

Auvray M, Elaidi R, Ozguroglu M, Guven S, Gauthier H, Culine S, Caty A, Dujardin C, Auclin E, Thibaut C, Combe P, Tartour E, Oudard S.

Clin Genitourin Cancer. 2017 Jun;15(3):e469-e476. doi: 10.1016/j.clgc.2016.10.013. Epub 2016 Nov 16.

PMID:
27964892
4.

[Alternative prescription schedules of sunitinib in metastatic kidney cancer: from the underground to the light?].

Thiery-Vuillemin A, Mouillet G, Pouessel D, Barthelemy P, Caty A, Sebbagh S, Vanno YA, Laplaige P, Cheverau C, Ravaud A.

Bull Cancer. 2014 Sep;101(9):832-40. doi: 10.1684/bdc.2014.2020. Review. French.

PMID:
25295955
5.

A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.

Selle F, Wittnebel S, Biron P, Gravis G, Roubaud G, Bui BN, Delva R, Bay JO, Fléchon A, Geoffrois L, Caty A, Soares DG, de Revel T, Fizazi K, Gligorov J, Micléa JM, Dubot C, Provent S, Temby I, Gaulet M, Horn E, Brindel I, Lotz JP.

Ann Oncol. 2014 Sep;25(9):1775-82. doi: 10.1093/annonc/mdu198. Epub 2014 Jun 3.

PMID:
24894084
6.

Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib.

Beuselinck B, Lambrechts D, Van Brussel T, Wolter P, Cardinaels N, Joniau S, Lerut E, Karadimou A, Couchy G, Sebe P, Ravaud A, Zerbib M, Caty A, Paridaens R, Schöffski P, Verkarre V, Berger J, Patard JJ, Zucman-Rossi J, Oudard S.

Acta Oncol. 2014 Oct;53(10):1413-22. doi: 10.3109/0284186X.2014.918276. Epub 2014 May 30.

PMID:
24874929
7.

A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.

Fizazi K, Delva R, Caty A, Chevreau C, Kerbrat P, Rolland F, Priou F, Geoffrois L, Rixe O, Beuzeboc P, Malhaire JP, Culine S, Aubelle MS, Laplanche A.

Eur Urol. 2014 Feb;65(2):381-6. doi: 10.1016/j.eururo.2013.09.004. Epub 2013 Sep 13.

PMID:
24094847
8.

Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma?

Vanhuyse M, Penel N, Caty A, Fumagalli I, Alt M, Zini L, Adenis A.

Bull Cancer. 2012 Dec;99(12):100-6. doi: 10.1684/bdc.2012.1672.

9.

[Androgen deprivation therapy for prostate cancer and osteoporotic risk].

Cortet B, Lartigau E, Caty A, Moulinier F, Staerman F, Villamizar-Vesga J, Villers A.

Prog Urol. 2012 Sep;22 Suppl 2:S31-8. doi: 10.1016/S1166-7087(12)70034-9. French.

PMID:
23098788
10.

Complete remission with tyrosine kinase inhibitors in renal cell carcinoma.

Albiges L, Oudard S, Negrier S, Caty A, Gravis G, Joly F, Duclos B, Geoffrois L, Rolland F, Guillot A, Laguerre B, Legouffe E, Kohser F, Dietrich PY, Theodore CA, Escudier B.

J Clin Oncol. 2012 Feb 10;30(5):482-7. doi: 10.1200/JCO.2011.37.2516. Epub 2012 Jan 9.

PMID:
22231040
11.

[Pleuro-pulmonary metastases from a malignant mesothelioma of the tunica vaginalis].

Pannier D, Caty A, Hysi I, Bouchindhomme B, Copin MC, Porte H, Dansin E.

Rev Mal Respir. 2011 Nov;28(9):1155-7. doi: 10.1016/j.rmr.2011.05.009. Epub 2011 Oct 12. French.

PMID:
22123142
12.

Prostate cancer related haemophagocytic syndrome: successful treatment with chemotherapy.

Declerck L, Adenis C, Amela E, Caty A, Adenis A, Penel N.

Acta Oncol. 2012 Feb;51(2):268-9. doi: 10.3109/0284186X.2011.608377. Epub 2011 Sep 22. No abstract available.

PMID:
21936755
14.

Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.

Bellmunt J, Théodore C, Demkov T, Komyakov B, Sengelov L, Daugaard G, Caty A, Carles J, Jagiello-Gruszfeld A, Karyakin O, Delgado FM, Hurteloup P, Winquist E, Morsli N, Salhi Y, Culine S, von der Maase H.

J Clin Oncol. 2009 Sep 20;27(27):4454-61. doi: 10.1200/JCO.2008.20.5534. Epub 2009 Aug 17. Erratum in: J Clin Oncol. 2010 Jan 1;28(1):182. Winquist, Eric [added].

PMID:
19687335
15.

Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.

Besse B, Grunenwald D, Fléchon A, Caty A, Chevreau C, Culine S, Théodore C, Fizazi K.

J Thorac Cardiovasc Surg. 2009 Feb;137(2):448-52. doi: 10.1016/j.jtcvs.2008.09.032.

16.

Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.

James ND, Caty A, Borre M, Zonnenberg BA, Beuzeboc P, Morris T, Phung D, Dawson NA.

Eur Urol. 2009 May;55(5):1112-23. doi: 10.1016/j.eururo.2008.11.002. Epub 2008 Nov 29.

PMID:
19042080
17.

[Gastric or duodenal metastases from clear cell renal cell carcinoma. Report of two cases and review of the literature].

Haffner J, Morel JF, Maunoury V, Caty A, Biserte J, Villers A.

Prog Urol. 2007 Nov;17(7):1305-9. Review. French.

PMID:
18271411
18.

Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.

Culine S, Kramar A, Théodore C, Geoffrois L, Chevreau C, Biron P, Nguyen BB, Héron JF, Kerbrat P, Caty A, Delva R, Fargeot P, Fizazi K, Bouzy J, Droz JP; Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.

J Clin Oncol. 2008 Jan 20;26(3):421-7. doi: 10.1200/JCO.2007.13.8461.

PMID:
18202419
19.

[Endoscopic treatment of hemorrhagic gastric metastases in renal cell carcinoma].

Maunoury V, Morel JF, Wacrenier A, Bulois P, Caty A, Klein O, Villers A.

Gastroenterol Clin Biol. 2007 Oct;31(10):858-9. French. No abstract available.

20.

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial.

Negrier S, Perol D, Ravaud A, Chevreau C, Bay JO, Delva R, Sevin E, Caty A, Escudier B; French Immunotherapy Intergroup.

Cancer. 2007 Dec 1;110(11):2468-77.

21.

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).

Culine S, Kerbrat P, Kramar A, Théodore C, Chevreau C, Geoffrois L, Bui NB, Pény J, Caty A, Delva R, Biron P, Fizazi K, Bouzy J, Droz JP; Genito-Urinary Group of the French Federation of Cancer Center (GETUG T93BP).

Ann Oncol. 2007 May;18(5):917-24. Epub 2007 Mar 9.

PMID:
17351252
22.

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial.

Lotz JP, Bui B, Gomez F, Théodore C, Caty A, Fizazi K, Gravis G, Delva R, Peny J, Viens P, Duclos B, De Revel T, Curé H, Gligorov J, Guillemaut S, Ségura C, Provent S, Droz JP, Culine S, Biron P; Groupe d'Etudes des Tumeurs Uro-Génitales (GETUG).

Ann Oncol. 2005 Mar;16(3):411-8. Epub 2005 Jan 19.

PMID:
15659420
23.

[Imaging of testicular tumors].

Thoumas D, Caty A, Gobet F, Lemaître L.

J Radiol. 2002 Jun;83(6 Pt 2):883- 93, discussion 894-6. Review. French.

24.

[Cl958].

Lansiaux A, Caty A, Deligny N, Bailly C.

Bull Cancer. 2002 Jun;89(6):575-8. French. No abstract available.

25.

Phase II study of vinorelbine in patients with androgen-independent prostate cancer.

Oudard S, Caty A, Humblet Y, Beauduin M, Suc E, Piccart M, Rolland F, Fumoleau P, Bugat R, Houyau P, Monnier A, Sun X, Montcuquet P, Breza J, Novak J, Gil T, Chopin D.

Ann Oncol. 2001 Jun;12(6):847-52.

PMID:
11484963
28.

Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer.

Kolesnikov-Gauthier H, Carpentier P, Depreux P, Vennin P, Caty A, Sulman C.

J Nucl Med. 2000 Oct;41(10):1689-94.

29.

[Laparoscopic lumbo-aortic lymphadenectomy in early-stage non-seminomatous germ cell tumors of the testis: Why? How?].

Leblanc E, Caty A, Dargent D, Querleu D, Mazeman E.

Prog Urol. 2000 Jun;10(3):379-87. French.

PMID:
10951930
30.

Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape.

Escudier B, Chevreau C, Lasset C, Douillard JY, Ravaud A, Fabbro M, Caty A, Rossi JF, Viens P, Bergerat JP, Savary J, Négrier S.

J Clin Oncol. 1999 Jul;17(7):2039-43.

PMID:
10561255
31.

Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie.

Ravaud A, Audhuy B, Gomez F, Escudier B, Lesimple T, Chevreau C, Douillard JY, Caty A, Geoffrois L, Ferrero JM, Linassier C, Drevon M, Négrier S.

J Clin Oncol. 1998 Aug;16(8):2728-32.

PMID:
9704724
32.

The diagnostic value of urinary Crosslaps and serum alkaline phosphatase in patients with prostate cancer.

Nguyen-Pamart M, Caty A, Feutrie ML, Fournier C, Gosselin P, Mazeman E.

Br J Urol. 1997 Sep;80(3):452-5.

PMID:
9313666
33.

[Unusual development of nonseminomatous germ cell tumors of the testis (NSGCT)].

Caty A, Depadt G, Feutry ML.

Bull Cancer. 1997 Aug;84(8):796-9. French.

34.

[Spermatocytic seminoma. Apropos of 4 cases].

Caty A, Bertrand P, Castelain B, Mazeman E.

Bull Cancer. 1997 Feb;84(2):212-4. French.

35.

Rapidly recycled, intensive alternating chemotherapy in heavily pretreated progressive nonseminomatous germ cell tumors a feasibility study.

Culine S, Droz JP, Delva R, Bui B, Caty A, Minier B, Mital P, Mousseau M.

Urol Oncol. 1995 May-Jun;1(3):109-14.

PMID:
21224102
36.

Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors.

Douchez J, Droz JP, Desclaux B, Allain Y, Fargeot P, Caty A, Charrot P.

J Urol. 1993 Mar;149(3):498-501.

PMID:
8382321
37.

Experimental studies and preliminary clinical trial of vinorelbine-loaded polymeric bioresorbable implants for the local treatment of solid tumors.

Fournier C, Hecquet B, Bouffard P, Vert M, Caty A, Vilain MO, Vanseymortier L, Merle S, Krikorian A, Lefebvre JL, et al.

Cancer Res. 1991 Oct 1;51(19):5384-91.

38.

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience.

Boutan-Laroze A, Mahjoubi M, Droz JP, Charrot P, Fargeot P, Kerbrat P, Caty A, Voisin PM, Spielmann M, Rey A, et al.

Eur J Cancer. 1991;27(12):1690-4.

PMID:
1782084
39.

A randomized double-blind study evaluating Anandron associated with orchiectomy in stage D prostate cancer.

Namer M, Toubol J, Caty A, Couette JE, Douchez J, Kerbrat P, Droz JP.

J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):909-15.

PMID:
2285605
40.

[Cancer of the upper aerodigestive tract. Global study of 2418 cases].

Lefebvre JL, Cambier L, Coche-Dequeant B, Joveniaux A, Lesoin-Montaigne A, Buisset E, Prevost B, Caty A, Castelain B, Vankemmel B.

Bull Cancer. 1989;76(7):763-70. Review. French.

PMID:
2684302
41.

[Nonseminomatous testicular tumors. Diagnostic strategy. Apropos of 53 cases].

Mazeman E, Denis LA, Denis X, Caty A, Rigot JM.

Ann Urol (Paris). 1988;22(5):345-9. French.

PMID:
3059988
42.

Significance of PSA and PAP in patients with or without prostatic cancer.

Caty A, Gosselin P, Cazin JL, Dehaut JM, Adenis L.

Am J Clin Oncol. 1988;11 Suppl 2:S63-4.

PMID:
2468275
43.

[Basal cell nevus syndrome: apropos of a case].

Caty A, Coche-Dequeant B, Flipo RM, Adenis L.

Bull Cancer. 1987;74(3):261-3. French. No abstract available.

PMID:
3620731
44.
45.

[Cancer of the prostate: therapeutic strategy in 1985].

Caty A, Cappelaere P, Demaille A.

Bull Cancer. 1986;73(1):81-4. French.

PMID:
3779126
46.

Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin.

Hecquet B, Vennin P, Fournier C, Lefebvre JL, Caty A, Bonneterre J, Adenis L, Demaille A.

Cancer Chemother Pharmacol. 1985;15(3):310-2.

PMID:
4053273
47.

[Changes in mean erythrocyte volume during cisplatin treatment].

Vennin P, Hecquet B, Dhondt J, Granier AM, Caty A, Demaille MC.

Bull Cancer. 1985;72(1):55-7. French. No abstract available.

PMID:
4039207
48.

[Combination of cisplatin with 5-fluorouracil in the primary treatment of advanced carcinoma of the upper respiratory and digestive tract].

Joveniaux A, Caty A, Adenis L.

Bull Cancer. 1984;71(4):390. French. No abstract available.

PMID:
6541953
49.

[Detection-prevention of gynecologic and breast cancers; a 10-year pinpointing experience].

Adenis L, Caty A, Horner D, Besson P, Servent V, Lesoin A, Pottier G, Lourme J, Demaille A.

LARC Med. 1983 Jun-Jul;3(6):422, 425. French. No abstract available.

PMID:
6888111
50.

[Granular cell myoblastoma. Review of the literature apropos of 3 cases].

Lesoin A, Delobelle A, Granier AM, Caty A.

LARC Med. 1983 Apr;3(4):232-5. French. No abstract available.

PMID:
6312222

Supplemental Content

Support Center